Ping An Healthcare Stock Price To Sales

1XZ Stock  EUR 1.75  0.03  1.74%   
Ping An Healthcare fundamentals help investors to digest information that contributes to Ping An's financial success or failures. It also enables traders to predict the movement of Ping Stock. The fundamental analysis module provides a way to measure Ping An's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ping An stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ping An Healthcare Company Price To Sales Analysis

Ping An's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Ping An Price To Sales

    
  0.54 X  
Most of Ping An's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ping An Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, Ping An Healthcare has a Price To Sales of 0.5416 times. This is 97.47% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The price to sales for all Germany stocks is 95.26% higher than that of the company.

Ping Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ping An's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ping An could also be used in its relative valuation, which is a method of valuing Ping An by comparing valuation metrics of similar companies.
Ping An is currently under evaluation in price to sales category among its peers.

Ping Fundamentals

About Ping An Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ping An Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ping An using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ping An Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Ping Stock

Ping An financial ratios help investors to determine whether Ping Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ping with respect to the benefits of owning Ping An security.